Levothyroxine Mercury Pharma Group

Levothyroxine, the active ingredient in Levothyroxine Mercury Pharma Group, is a thyroid hormone presented as an oral tablet for oral use. It replaces deficient thyroid hormone and is used to treat hypothyroidism, thyroid hormone replacement needs, and goiter in adults and children.

GNH USA supplies Levothyroxine Mercury Pharma Group as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The product conforms to EU market standards and is manufactured under GMP conditions.

Levothyroxine is used in thyroid‑related disorders to restore normal hormone levels.

- Hypothyroidism: restores deficient thyroid hormone and normalizes metabolism. - Thyroid hormone replacement: provides synthetic T4 for patients requiring lifelong hormone supplementation. - Goiter: reduces thyroid gland enlargement by normalizing hormone feedback.

Levothyroxine may cause a range of adverse reactions, most of which are dose‑related and reversible.

Common Side Effects: - Headache: mild to moderate discomfort. - Insomnia: difficulty falling or staying asleep. - Palpitations: sensation of rapid or irregular heartbeat. - Weight loss: unintended reduction in body weight. - Heat intolerance: increased sensitivity to warm environments. - Tremor: fine shaking of hands or limbs.

Serious or Rare Side Effects: - Angina or myocardial infarction: chest pain or heart attack in susceptible patients. - Arrhythmia: abnormal heart rhythm that may be life‑threatening. - Osteoporosis or bone loss: reduced bone mineral density with long‑term excess dosing. - Allergic reaction: rash, angioedema, or anaphylaxis. - Adrenal insufficiency: exacerbation of underlying adrenal disease. - Severe hyperthyroid symptoms: agitation, fever, or delirium.

Levothyroxine requires careful monitoring and individualized dosing to avoid over‑ or under‑replacement.

- Dose adjustment: tailor dose based on thyroid function tests and patient response. - Cardiovascular disease: monitor closely in patients with coronary artery disease or arrhythmias. - Elderly patients: start with a lower dose to reduce cardiac stress. - Pregnancy: use only if clearly needed; discuss risks with the prescribing clinician. - Drug interactions: review concomitant medications for potential interactions. - Store at ambient temperature: keep in the original container, protect from moisture and light.

Levothyroxine absorption and activity can be altered by several co‑administered agents.

Major Interactions (Avoid): - Antithyroid drugs (e.g., methimazole, propylthiouracil): block levothyroxine effect. - Calcium or iron supplements: reduce absorption if taken simultaneously. - Orlistat: decreases levothyroxine bioavailability. - Warfarin: may enhance anticoagulant effect, requiring INR monitoring. - Amiodarone: alters thyroid hormone metabolism.

Moderate Interactions (Monitor Closely): - Beta‑blockers: may mask symptoms of excess thyroid hormone. - Corticosteroids: increase levothyroxine clearance. - Estrogen therapy: may increase levothyroxine requirement. - Cholestyramine: reduces absorption. - Serotonergic antidepressants: may affect thyroid hormone levels.